Radiochemicals

Lutetium-177

Availability · Weekly

6.7 days: Half life
Lu-177 > 99.95%: Radionuclidic purity
100 mCi/mL: Concentration

Clinical overview

Lutetium is used in a radiation-based treatment that utilizes a molecule to attach itself to the PSMA receptors located on the cancer cells. Lutetium-177 emits beta radiation that effectively damages cancer cells and, over time, destroys them.Lu-177 C. A and Lu-177 N.C.A, we can provide you both products. In addition, we can provide both carrier-added and no-carrier-added Lu-177.

Product data

5 fields · 4 populated

Half life: 6.7 days
Radionuclidic purity: Lu-177 > 99.95%
Concentration: 100 mCi/mL
Specific activity: 1.3 Ci/mg at production >1.0 Ci/mg at reference date

On request Radiochemical purity

Ask a specialist

Weekly supply windows

Calibrated to your delivery date, shipped from qualified reactor and cGMP partners.

Regulatory support

DMF assistance and documentation for Canada, USA and Latin America filings.

Cold-chain logistics

Type A packaging, licensing and customs handled by our regional order desks.

Related Radiochemicals

Thinking… Something went wrong. Please try again.